Next-generation sequencing in adventitious agent testing: navigating regulatory acceptance
Olaf Stamm, Horst Ruppach, Minu Youngkin
Achieving rapid microbiological monitoring in fill-finish with biofluorescent particle counters: a collaborative case study
M Dingle, A Carwell, M J. Miller et al
Fit-for-purpose analytical development for an emerging cell therapy landscape
J Wei, D Rill, F Durst et al
Strategies for streamlined manufacturing and analytics in CGT development
Laura Mueller, Silvio Weber, Dirk Windgassen
Transforming cell therapy manufacturing: smart automation & genetic modification for scalable success
Peter Szaraz, Tessel Hammink
AAV capsid analysis and quantification with chromatography and ultracentrifugation-based techniques
Andreja Livk, Sebastijan Peljhan
Modernizing viral clearance study strategy: regulatory updates and industry best practices
Audrey Chang, Kathleen Kenney
Big pharma case study: alpha testing of a generic anti-AAV kit and comparison to in-house methods
Kira Hedström, Eva-Maria Thüring
